Acelrx Pharmaceuticals reported $570K in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.57M 0.13M
Baxter International BAX:US $ 3746M 39M
Becton, Dickinson and BDX:US $ 4641M 370M
Cara Therapeutics CARA:US $ 23M 18.21M
Heron Therapeutics HRTX:US $ 27.63M 4.17M
Intra Cellular Therapies ITCI:US $ 55.58M 20.58M
Johnson & Johnson JNJ:US $ 24020M 594M
Pfizer PFE:US $ 27742M 2081M
Smiths SMIN:LN 137.4B 18.2B
Teva Pharmaceutical TEVA:IT 3.79B 125M
Xeris Pharmaceuticals Inc XERS:US $ 25.31M 3.23M